1. Home
  2. LI vs DGX Comparison

LI vs DGX Comparison

Compare LI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Li Auto Inc.

LI

Li Auto Inc.

HOLD

Current Price

$16.37

Market Cap

17.5B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$176.83

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LI
DGX
Founded
2015
1967
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5B
20.5B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
LI
DGX
Price
$16.37
$176.83
Analyst Decision
Hold
Buy
Analyst Count
8
13
Target Price
$21.04
$196.69
AVG Volume (30 Days)
4.1M
883.2K
Earning Date
11-26-2025
02-10-2026
Dividend Yield
N/A
1.80%
EPS Growth
N/A
14.49
EPS
0.62
8.51
Revenue
$17,952,966,790.00
$10,850,000,000.00
Revenue This Year
N/A
$12.37
Revenue Next Year
$26.33
$3.52
P/E Ratio
$27.08
$20.88
Revenue Growth
N/A
13.74
52 Week Low
$16.11
$148.70
52 Week High
$33.12
$197.55

Technical Indicators

Market Signals
Indicator
LI
DGX
Relative Strength Index (RSI) 35.89 45.88
Support Level $16.82 $171.18
Resistance Level $17.74 $181.23
Average True Range (ATR) 0.43 2.55
MACD 0.07 0.44
Stochastic Oscillator 6.69 56.14

Price Performance

Historical Comparison
LI
DGX

About LI Li Auto Inc.

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: